About the bill
- Summary (CRS)
- 9/25/1992--Introduced.Amends Federal patent law to permit separate patent extensions for certain drug products: (1) under a patent which is subject to full regulatory review and approval; and (2) which were ... Read more >
- What is a bill?
The “H.R.” in “H.R. 6038” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 6038 — 102nd Congress: To amend title 35, United States Code, to permit separate patent extensions for each product .... Retrieved from https://www.govtrack.us/congress/bills/102/hr6038
“H.R. 6038 — 102nd Congress: To amend title 35, United States Code, to permit separate patent extensions for each product ....” www.GovTrack.us. 1992. May 26, 2015 <https://www.govtrack.us/congress/bills/102/hr6038>
|title=H.R. 6038 (102nd)
|accessdate=May 26, 2015
|author=102nd Congress (1992)
|date=September 25, 1992
|quote=To amend title 35, United States Code, to permit separate patent extensions for each product ...